Alastair Thompson was named section chief of breast surgery in the Michael E. DeBakey Department of Surgery, Division of Surgical Oncology, and co-director of the Lester and Sue Smith Breast Center, part of the Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine.
Richard Drachtman, clinical section chief of the Pediatric Hematology/Oncology Division at Rutgers Cancer Institute of New Jersey, received the 2018 recipient of the Melvyn H. Motolinsky Research Foundation Distinguished Service Award in recognition of his accomplishments and leadership in the field of pediatric cancer and blood disorders.
Mount Sinai Hospital has launched the Mount Sinai Mobile Mammography Program, bringing essential breast cancer detection services and education to women in New York City.
Researchers, cancer patients, and philanthropists have come together to launch Count Me In, a new nonprofit organization and model of patient-partnered research. Count Me In allows cancer patients anywhere in the United States or Canada to easily share their medical information, personal experience, and tumor samples for genetic analysis, propelling progress against cancer. Patient information is rapidly processed, de-identified and made available to all researchers worldwide.
A cross-disciplinary Roswell Park Comprehensive Cancer Center team submitted the winning application to establish and house a Data Management and Resource-Sharing Center to serve the Immuno-Oncology Translational Network, which directly responds to the goals of the Moonshot.
Michel Sadelain, director of the Center for Cell Engineering at Memorial Sloan Kettering Cancer Center, has been awarded the Pasteur-Weizmann/Servier International Prize.
The American Cancer Society has announced five winners the Medal of Honor.
The American Cancer Society Cancer Action Network has published “Cancer Disparities: A Chartbook,” a report that includes more than 100 charts and maps detailing the extent of disparities across different populations.
A memorial service for Alan Rabson will take place on Oct. 30, from 2 to 4 p.m., at the Ruth L. Kirschstein Auditorium, Natcher Conference Center in Bethesda, MD.
Steven Artandi, professor of medicine and of biochemistry at the School of Medicine, was named director of the Stanford Cancer Institute effective Oct. 1.
